Literature DB >> 32810844

Thyroid cancer in the age of COVID-19.

Venessa H M Tsang1,2, Matti Gild1,2,3, Anthony Glover2,4, Roderick Clifton-Bligh1,2,3, Bruce G Robinson1,2,3.   

Abstract

COVID-19 has modified the way we practice medicine. For thyroid cancer, there have been several significant impacts. First, the diagnosis has been delayed due to social isolation, reduced access to investigations and staff redeployment. Secondly, treatment planning has needed to take into account the risk to patients and/or staff of nosocomial transmission of the virus. Finally, there are some specific concerns with respect to interactions between the virus, its treatments and cancer. This mini-review aims to address each of these impacts and to provide some guidance and confidence to our patients and colleagues during this challenging time.

Entities:  

Keywords:  COVID-19; radioactive iodine; thyroid cancer; tyrosine kinase inhibitor

Mesh：

Substances：

Year:  2020        PMID： 32810844     DOI： 10.1530/ERC-20-0279

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


  11 in total

Review 1.  Impact of COVID-19 on the thyroid gland: an update.

Authors:  Lorenzo Scappaticcio; Fabián Pitoia; Katherine Esposito; Arnoldo Piccardo; Pierpaolo Trimboli
Journal:  Rev Endocr Metab Disord       Date:  2020-11-25       Impact factor: 6.514

2.  The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study.

Authors:  Mustafa Sahin; Cem Haymana; Ibrahim Demirci; Ilker Tasci; Emral Rıfat; Ugur Unluturk; Ilhan Satman; Tevfik Demir; Erman Cakal; Naim Ata; Derun Ertugrul; Serpil Salman; Ibrahim Sahin; Selcuk Dagdelen; Osman Celik; Murat Caglayan; Aysegul Atmaca; Alper Sonmez
Journal:  Clin Endocrinol (Oxf)       Date:  2021-05-03       Impact factor: 3.523

3.  Decision-making in Surgery or Active Surveillance for Low Risk Papillary Thyroid Cancer During the COVID-19 Pandemic.

Authors:  Anna M Sawka; Sangeet Ghai; Ogemdi Ihekire; Jennifer M Jones; Amiram Gafni; Nancy N Baxter; David P Goldstein
Journal:  Cancers (Basel)       Date:  2021-01-20       Impact factor: 6.639

4.  Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic.

Authors:  Raffaele Palladino; Ilaria Migliatico; Roberta Sgariglia; Mariantonia Nacchio; Antonino Iaccarino; Umberto Malapelle; Elena Vigliar; Domenico Salvatore; Giancarlo Troncone; Claudio Bellevicine
Journal:  Endocrine       Date:  2020-12-07       Impact factor: 3.633

5.  The PanSurg-PREDICT Study: Endocrine Surgery During the COVID-19 Pandemic.

Authors:  K Van Den Heede; S Chidambaram; J Winter Beatty; N Chander; S Markar; N S Tolley; F F Palazzo; J K Kinross; A N Di Marco
Journal:  World J Surg       Date:  2021-04-20       Impact factor: 3.352

6.  More Aggressive Cancer Behaviour in Thyroid Cancer Patients in the Post-COVID-19 Pandemic Era: A Retrospective Study.

Authors:  Hanqing Liu; Ling Zhan; Liantao Guo; Xizi Yu; Lingrui Li; Hongfang Feng; Dan Yang; Zhiliang Xu; Yi Tu; Chuang Chen; Shengrong Sun
Journal:  Int J Gen Med       Date:  2021-10-27

Review 7.  Updated clinical management guidance during the COVID-19 pandemic: thyroid nodules and cancer.

Authors:  Evanthia Giannoula; Ioannis Iakovou; Luca Giovanella; Alexis Vrachimis
Journal:  Eur J Endocrinol       Date:  2022-02-28       Impact factor: 6.664

8.  Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19.

Authors:  Reagan A Collins; Catherine DiGennaro; Toni Beninato; Rajshri M Gartland; Natalia Chaves; Jordan M Broekhuis; Lekha Reddy; Jenna Lee; Angelina Deimiller; Maeve M Alterio; Michael J Campbell; Yeon Joo Lee; Tyler K Khilnani; Latoya A Stewart; Mollie A O'Brien; Miguel Valdivia Y Alvarado; Feibi Zheng; David McAneny; Rachel Liou; Catherine McManus; Sophie Y Dream; Tracy S Wang; Tina W Yen; Amal Alhefdhi; Brendan M Finnerty; Thomas J Fahey; Claire E Graves; Amanda M Laird; Matthew A Nehs; Frederick Thurston Drake; James A Lee; Christopher R McHenry; Benjamin C James; Janice L Pasieka; Jennifer H Kuo; Carrie Cunningham Lubitz
Journal:  Surgery       Date:  2022-08-29       Impact factor: 4.348

9.  Thyroid surgery during the COVID-19 pandemic: results from a systematic review.

Authors:  L Scappaticcio; M I Maiorino; S Iorio; C Camponovo; A Piccardo; G Bellastella; G Docimo; K Esposito; P Trimboli
Journal:  J Endocrinol Invest       Date:  2021-07-19       Impact factor: 4.256

Review 10.  COVID-19 and Thyroid Diseases: A Bidirectional Impact.

Authors:  Leonidas H Duntas; Jacqueline Jonklaas
Journal:  J Endocr Soc       Date:  2021-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.